Health officers to offer Molnupiravir and Paxlovid to Covid-19 sufferers in Thailand

Two anti-viral medications shall be added to the Covid-19 remedy plan in Thailand. The Department of Medical Services shared that the Molnupiravir and Paxlovid medicines have been accredited for treating Covid-19 sufferers. Molnupiravir is meant to deal with high-risk groups like elders and patients with persistent illnesses. Relevant departments will focus on using Paxlovid. The primary Covid-19 medicine, the anti-viral Favipiravir, will be limited for patients with average and severe signs solely.
The director of the division, Somsak Akkasilp, shared that the authorities will talk about the distribution and use particulars later. There may also be a research on the effectiveness of utilizing Molnupiravir, Paxlovid, and Favipiravir to give you a plan to make use of the medicines reasonably and successfully.
In less than of Public Health knowledgeable that the Covid-19 remedy plan in Thailand could be adjusted according to the situation. Recently, the authorities shared Home Isolation and Community Isolation can be the first remedy supplied to sufferers with gentle signs.
A pulmonary illness skilled at Vichaiyut Hospital told Thai media that Molnupiravir might help cut back the severity of the disease and dying rates by about 30%. He mentioned the drugs would be given to patients at high danger.
SOURCE: WorkpointTODAY | Thairath

Leave a Comment